HSC Technology Group Limited is pleased to announce it has appointed two international finance and healthcare industry executives to its Advisory Board to assist in the growth of the Company and improve its value and performance.
Eugene Lim and Martin Robinson will take up the roles after HSC determined to implement a number of operational and other enhancements, including the establishment of the Advisory Board.
Mr Lim is a former Managing Director at Credit Suisse (Asia) where he was employed for over 19 years including roles as CEO of Credit Suisse Securities Singapore, responsible for overseeing all equities securities business conducted in the country, and head of ASEAN Equity Sales, responsible for managing the equity distribution business in all ASEAN offices. His positions included being a conduit between Capital Markets and Corporate Finance teams on numerous transactions and public offerings in the region. For the past six years he has advised on private equity transactions in the Asia Pacific region for family offices and wealth management companies.
Mr Robinson has over 20 years of growth and private equity investing, C-suite, investment committee, corporate finance and legal experience including over US$2 billion of healthcare investments/exits across Asia, Australia, Africa and the Middle East since 2010. He is a founding partner of HEAL Partners, a health, education and lifestyle growth stage private equity fund. He previously led the healthcare private equity strategy for a multi-billion dollar private investment group based in Singapore, originating and leading the US$123 million acquisition of Hoan My Medical Corporation, and as Chairman, led the transformation of the group into Vietnam’s leading hospital network. He also originated and led the Series A round investment into HaloDoc, Indonesia’s leading health tech mobile platform and was a Board member.
Mr Robinson previously worked for the Religare/Fortis Healthcare Group in Singapore where he was responsible for several landmark healthcare principal investments across Asia-Pacific including the acquisition of Quality Healthcare Hong Kong, Radlink Singapore and the takeover of Dental Corp Australia. He also spent five years with Macquarie Bank (Australia & Hong Kong), where he was responsible for the Group’s Asian principal investments and Head of Sponsor Coverage Asia.
Managing Director, Graham Russell, said HSC was excited to welcome the calibre and experience of Mr Lim and Mr Robinson to their Advisory Board and looked forward to working with them to grow value for the Company.
“The Advisory Board has been established to provide guidance, advice and networking assistance to the HSC Board and senior management of the Company in respect of our business and operations,” he said.
“The counsel we are seeking includes the identification, analysis and management of opportunities and risks and the full range of commercial, political, legal and other issues which could have a material influence on the Company’s ability to successfully achieve our vision of becoming the industry leader.
“Our focus is to provide a world class proprietary data analytics platform that utilises a range of globally sourced IoT enabled devices and sensors to deliver decision-making insights to clients, their families and medical practitioners to ultimately improve people’s safety, independence, autonomy and most importantly improve their lives.
“We are confident that both Mr Lim’s and Mr Robinson’s extensive experience in the finance and healthcare fields will help drive this, and their appointment bolsters our management and executive team to one of the most qualified in our industry.”